Cwm, LLC Pyxis Oncology, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Cwm, LLC holds 344 shares of PYXS stock, worth $581. This represents 0.0% of its overall portfolio holdings.

Number of Shares

344

Holding current value

$581

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 08, 2024	BUY	$2.83 - $3.94 $973 - $1,355	344 New	344 $1,000
Q2 2023 Aug 03, 2023	BUY	$2.46 - $4.07 $226 - $374	92 New	92 $0

Others Institutions Holding PYXS

# of Institutions

101

Shares Held

28.2M

Call Options Held

539K

Put Options Held

54.1K

Deep Track Capital, LP Greenwich, CT

4.18M
Shares

$7.07 Million
0.57% of portfolio
Laurion Capital Management LP New York, NY

3.63M
Shares

$6.13 Million
0.18% of portfolio
Black Rock Inc. New York, NY

2.79M
Shares

$4.71 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$4.11 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.91M
Shares

$3.22 Million
0.0% of portfolio

View Full List

About Pyxis Oncology, Inc.

Ticker PYXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,096,400
Market Cap $59.3M
Description
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...

More about PYXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account